AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care
- Cencora unifies its employees under one identity and emphasizes its vision for creating healthier futures
- Company commits $5 million to global corporate philanthropic efforts
- None.
New name of company reflects unified global presence and collective goal of creating healthier futures by accelerating positive outcomes for customers and their patients
Company announces more than
Under the new name Cencora, the company unifies its 46,000 employees – across several global business segments – under one identity, propelled by a bold vision and purpose-driven approach to creating healthier futures.
The new name underscores Cencora’s experience and vision when it comes to connecting manufacturers, providers, pharmacies and patients, and ensuring the consistent, reliable flow of treatments to those who need them at a time of growing complexity.
"Today is a significant and exciting milestone for Cencora. Our new name is a reminder of our customers, their patients, and our team members who are at the center of everything we do,” said Steven H. Collis, Chairman, President & Chief Executive Officer of Cencora. “It represents the healthier futures we strive for serving as a trusted industry partner that prioritizes innovation, advocates for patient access, and advances strategic partnerships across the global pharmaceutical value chain.”
As a global healthcare company, Cencora will continue to invest in and focus on its core pharmaceutical distribution business, while also growing its platform of pharma and biopharma services to support pharmaceutical innovation and access across the globe.
Aligned with the company’s purpose, and to commemorate this seminal moment in the organization’s history, Cencora also announced a
The inaugural donation out of the Cencora Healthier Futures Grant Program will be a
“We are grateful for support from the Cencora Impact Foundation to help UNICEF deliver large-scale, sustainable results in ensuring the health of the world’s most vulnerable children,” said V. Renée Cutting, Chief Philanthropy Officer, UNICEF
Cencora Ventures, formerly known as AB Health Ventures, the company’s dedicated corporate venture fund, has also committed to donating
For more information about the rebrand and updated design and branding elements, visit: www.cencora.com
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than
View source version on businesswire.com: https://www.businesswire.com/news/home/20230830469400/en/
Media:
Lauren Esposito
215-460-6981
lesposito@amerisourcebergen.com
Investors:
Bennett S. Murphy
610-727-3693
bmurphy@amerisourcebergen.com
Source: Cencora